RRAGC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.747200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.506800E-01
Normal-vs-Stage2
6.729800E-01
Normal-vs-Stage3
4.589600E-02
Normal-vs-Stage4
3.476800E-01
Stage1-vs-Stage2
3.153600E-01
Stage1-vs-Stage3
4.495600E-01
Stage1-vs-Stage4
1.707930E-02
Stage2-vs-Stage3
1.727430E-01
Stage2-vs-Stage4
2.363600E-01
Stage3-vs-Stage4
3.455200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.407800E-01
Normal-vs-AfricanAmerican
9.124600E-01
Normal-vs-Asian
2.255400E-01
Caucasian-vs-AfricanAmerican
2.923800E-01
Caucasian-vs-Asian
2.367200E-01
AfricanAmerican-vs-Asian
1.431030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.141200E-01
Normal-vs-Female
5.178000E-01
Male-vs-Female
9.649600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.599600E-01
Normal-vs-Age(41-60Yrs)
9.976800E-01
Normal-vs-Age(61-80Yrs)
4.499800E-01
Normal-vs-Age(81-100Yrs)
1.684960E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.308800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.451400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.259200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.741600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.537830E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.142400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.640800E-01
Normal-vs-Daily Drinker
1.212400E-01
Normal-vs-Weekly Drinker
5.450800E-01
Normal-vs-Occasional Drinker
7.316400E-01
Normal-vs-Social Drinker
8.381200E-01
Non Drinker-vs-Daily Drinker
5.464400E-01
Non Drinker-vs-Weekly Drinker
4.719000E-01
Non Drinker-vs-Occasional Drinker
2.108800E-01
Non Drinker-vs-Social Drinker
1.378220E-01
Daily Drinker-vs-Weekly Drinker
2.300800E-01
Daily Drinker-vs-Occasional Drinker
9.014200E-02
Daily Drinker-vs-Social Drinker
5.509700E-02
Weekly Drinker-vs-Occasional Drinker
6.931600E-01
Weekly Drinker-vs-Social Drinker
5.412000E-01
Occasional Drinker-vs-Social Drinker
8.119200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.975600E-01
Normal-vs-Grade 2
8.751400E-01
Normal-vs-Grade 3
8.962400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.339100E-03
Grade 1-vs-Grade 3
1.287720E-02
Grade 1-vs-Grade 4
8.975600E-01
Grade 2-vs-Grade 3
7.258600E-01
Grade 2-vs-Grade 4
8.751400E-01
Grade 3-vs-Grade 4
8.962400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.859000E-01
Normal-vs-NonDiabetic
5.281200E-01
Diabetic-vs-NonDiabetic
6.553200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.647600E-01
Normal-vs-NoPancreatitis
5.471200E-01
Pancreatitis-vs-NoPancreatitis
9.224800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.147600E-01
Normal-vs-N1
7.243600E-01
N0-vs-N1
4.961900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.990000E-01
Normal-vs-TP53-NonMutant
4.516400E-01
TP53-Mutant-vs-TP53-NonMutant
1.257040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
